Thiazide diuretics normalize urinary calcium in spontaneously hypertensive male rats  by Fanestil, Darrell D. et al.
Kidney International, Vol. 51 (1997), PP. 1018—1021
Thiazide diuretics normalize urinary calcium in spontaneously
hypertensive male rats
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Thiazide diuretics normalize urinary calcium in spontaneously hyper.
tensive male rats. The role of the thiazide-sensitive distal convoluted
tubule (DCT) in the hypercalciuria of the spontaneously hypertensive rat
(SHR) strain was examined by determining (a) the renal density of the
thiazide diuretic receptor with 3H-metolazone, and (b) the renal response
to a maximal dose of bendrofiumethiazide (BFTZ). We confirm that the
renal thiazide receptor density was greater in SHR than WKY (0.936
0.026 vs. 0.797 0.045 pmol/mg protein; P = 0.02). Prior to BFTZ the
urinary excretion of calcium (0.525 0.061 vs. 0.274 0.049 mol per
mol creatinine, P < 0.01) and sodium (12.6 1.27 vs. 7.89 0.926 jrmol
per mol creatinine; P < 0.01) were greater in SHR versus WKY. BFTZ
decreased the excretion of calcium only in SHR and to a level (0.250
0.032) not significantly different (P = 0.519) from WKY (0.225 0.032).
Surprisingly, BFTZ increased chloride excretion to a greater extent in
WKY than in SHR (P = 0.008). We postulate that hypercalciuria in SHR
is a manifestation of incomplete uptake of calcium from the tubule lumen
across the apical cell membrane in the DCT of the SHR nephron.
The association of hypercalciuria with experimental hyperten-
sion, including the genetic hypertension in the SHR strain of rats,
has been the subject of considerable investigation [1—12]. Calcium
excretion is precisely regulated in the distal convoluted tubule
(DCT) of the rat nephron [13, 14]. Reabsorption of calcium from
the tubular fluid in the DCT occurs across the luminal cell
membrane, via dihydropyridine-sensitive Ca channels [15], into a
cytosol rich in vitamin D3 dependent Ca-binding protein 28 k
(CaBP2Sk), from which calcium is extruded across the basolateral
membrane via plasma membrane calcium ATPases (PMCA)
[16—18]. Recently, Suki and colleagues [19], comparing the SHR
and normotensive WKY strains, found decreased renal PMCA
abundance associated with increased renal abundance of CaBP2Sk
in SHR male animals, They concluded that hypercalciuria in SHR
results from decreased tubular reabsorption of calcium in the
DCT because the decreased PMCA limits the transport of calcium
from the cytosol across the basolateral membrane. This important
study highlights the role of the DCT in mediating hypercalciuria
in SHR. However, these interesting findings do not provide
information about the first step in the reabsorption of calcium
across the apical plasma membrane of the DCT cell. The present
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study provides additional indirect information about this issue.
We concur with Kamijo et al [19] that hypercalciuria in SHR is an
expression of incomplete calcium reabsorption in the DCT, but
suggest that the alteration is predominantly diminished uptake of
calcium at the luminal membrane of DCT cells.
Thiazide diuretic administration produces increased reabsorp-
tion of calcium from the distal nephron [14, 20] and, consequently,
decreased urinary excretion of calcium [21]. Thiazides are be-
lieved to inhibit a Na-Cl symporter in the apical plasma mem-
brane [22, 23] of early distal nephron cells [24—27]. This results in
decreased intracellular chloride, producing hyperpolarization of
the apical membrane and resulting opening of apical dihydropy-
ridine-sensitive Ca-channels, thereby facilitating entry of calcium
from tubular fluid into the cell [15, 28] and, hence, decreased
urinary excretion of calcium.
Our laboratory had previously documented that the density of
the pharmacological receptor for thiazide-type diuretics, as quan-
titated by the binding of 3H-metolazone [29], is greater in kidneys
of SHR than in age- and gender-matched WKY animals [30]. In
this report we demonstrate that acute administration of a thiazide
diuretic eliminates the hypercalciuria in male SHR hypertensive
animals. Thus, hypercalciuria in SHR appears to result from
incomplete calcium uptake from the tubular lumen into the
tubular cells of the DCT.
Methods
Male SHRLJ and WKYLJ, inbred in our La Jolla colony for over
a decade from progenitors obtained from Charles River Com-
pany, were used for all studies. All animals were bred and
maintained in an AALAC approved facility with free access to tap
water. All animals were fed a standard laboratory chow (#7002;
Harlan Teklad, Madison WI, USA) containing 1.91% calcium,
1.29% phosphorus, 0,52% sodium and 0.70% chloride. Studies
were initiated at 30 to 32 weeks of age. All experimental proce-
dures involving the animals were reviewed, approved and con-
ducted under review by the University of California San Diego
Animal Subjects Committee.
Blood pressure was measured by direct indwelling arterial
catheter. Briefly, rats were anesthetized with halothane and
arterial catheters were inserted via the femoral artery and ad-
vanced into the descending aorta below the bifurcation of the
renal arteries. The catheters were tunneled under the skin and
exteriorized via a dorsal route. Three days after catheter place-
ment arterial blood pressure was monitored with the animal
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conscious and only minimally restrained. The animal was placed
in a plastic cylinder located in a soundproof chamber with light,
air and white noise background. The animal could rotate in the
cylinder but could not rear. Measurements were made during the
morning to minimize circadian influences. Blood pressure was
measured with a Statham P23Db transducer coupled to a Gould
pressure processor. Heart rate was determined from the pulsatile
wave form by a Gould cardiotach. The analog data were recorded
on a Gould recorder and digitized for computer analysis. Arterial
blood was sampled for the various plasma determinations (see
below) via the indwelling catheter one to three days later.
One to three days later the animals were placed in individual
metabolic cages without access to food or water and urine was
collected in separate graduated cylinders over two two-hour time
periods, one prior and one subsequent to the intraperitoneal
injection of 0.3 mg/kg bendroflumethiazide (BFTZ) dissolved in
25% DMSO. Complete emptying of the bladder at the start and
end of each urine collection period was encouraged by gentle
massage over the urinary bladder. We have previously demon-
strated that this dose of BFTZ produces maximal natriuresis and
chloriuresis in male rats without altering the rate of glomerular
filtration [31]. Eight to 14 days later the animals were euthanized
under pentobarbital anesthesia (50 mg/kg) and the kidneys pro-
cessed for quantitation of thiazide receptor (see below).
Plasma and urine sodium and potassium were determined by
flame photometry (Instrumentation Laboratories). Urine and
plasma chloride and calcium, and urine creatinine were measured
by colorimetiy using commercially available kits (Sigma Chemical
Co. St. Louis, MO, USA). Arterial blood pH and pCO2 were
measured by electrodes (Instrumentation Laboratories) and bi-
carbonate and base excess concentrations were derived. Urinary
excretion of ions was expressed as the ratio of their individual
urine concentrations to that of urinary creatinine.
The renal density of the pharmacological receptor for thiazide-
type diuretics was quantitated by saturation analysis of renal
membranes with six concentrations of 3H-metolazone, ranging
from 0.313 nat to 10 nM, as previously detailed [29]. Specific
binding of 3H-metolazone is defined as that remaining in the
presence of excess (10 M) hydroflumethiazide. The density of
the binding sites was analyzed by the method of Scatchard using
the EBDA program of McPherson [321. Protein was determined
by the Bradford Coomassie blue method [331 with bovine gamma
globulin as the standard.
Data are expressed as mean SEM. Statistical significance was
assessed using the Statview statistical program (Abacus Con-
cepts, Inc., Berkeley, CA, USA). Student's t-test for paired
samples was utilized when excretion after bendroflumethiazide
was compared to excretion before the drug. Student's t-test for
unpaired samples was utilized when SHR and WKY animals were
compared.
Results
The mean arterial blood pressure of SHRLJ was nearly 50 mm
Hg higher than WKYLJ (Table 1). Although arterial pH was
nearly identical in the two strains, the plasma concentration of
bicarbonate was marginally lower in SHR than WKY (23.6
0,624 vs. 25.2 0.455 mmol/liter; P = 0.055). The plasma
concentration of total calcium was significantly greater in WKY
than SHR, but the absolute difference in concentration was less
than 0.1 mmol/liter (Table 1). However, the plasma concentra-
Table 1. Arterial pressure, plasma electrolytes and renal thiazide
diuretic receptor in WKY and SHR males
Parameter WKY SHR P
Mean arterial pressure 122 2.04 169 3.50 <0.001
mm Hg
Arterial pH 7.428 0.005 7.423 0.008 0.582
Plasma HC03 25.2 0.455 23.6 0.624 0.055
Plasma sodium 146 0.90 145 0.88 0.458
Plasma potassium 4.33 0.12 4.45 0.12 0.520
Plasma chloride 98.9 0.86 98.3 0.36 0.569
Plasma calcium 2.38 0.016 2.32 0.017 0.014
Thiazide receptor density 0.797 0.045 0.936 0.026 0.020
pmol/mg protein
Values are mean SEM and are mmol/liter, unless otherwise indicated.
N = 10 to 12 animals.
Table 2. Urinary excretion by WKY and SHR males before and after
bendroflumethiazide
Parameter WKY SHR P
Sodium
Before BFTZ 7.89 :t 0.926 12.6 1.27 0.008
After BFTZ 36.6 2.75 31.2 3.09 0.198
BFTZ a 26.7 258b 20.0 298k 0.108
Potassium
Before BFTZ 11.8 0.714 13.6 0.714 0.140
After BFTZ 24.1 1.58 19.3 1.03 0.022
BFTZ a 11.3 162b 6.21 171h 0.043
Chloride
Before BFTZ 9.26 1.15 11.24 1.76 0.153
After BFTZ 48.7 4.15 32.3 3.72 0.008
BFTZ Es" 37.1 390b 20.4 453b 0.012
Calcium
Before BFTZ 0.274 0.049 0.525 0.061 0.005
After BFTZ 0.225 0.021 0.250 0.032 0.519
BFTZ Es —0.060 0.039 —0.260 0.070 0.023
All values are mean SEM in i.smol ion per mol creatinine over a two
hour period. N = 10 to 12 animals.
BFTZ Es is the value after BFTZ minus the value before BFTZ.
BFTZ Es values are from the 9 animals in which paired collections were
obtained.
b BFTZ Es value is significantly different from zero at P 0.005
tions of sodium, potassium and chloride did not differ significantly
(Table 1). In confirmation of our prior study, the density of
thiazide diuretic receptor was greater in SHR than in WKY
kidney membranes, P < 0.02 (Table 1).
In the baseline pre-diuretic period, urinary excretion of sodium
was nearly 60% greater (P < 0.01), and urinary excretion of
calcium 90% greater (P < 0.01), in SHR than in WKY (Table 2).
Pre-diuretic urinary excretion of potassium and of chloride,
although tending to be greater in SHR, were not significantly
different between the two strains (Table 2).
Following BFTZ administration, urinary excretion of potassium
was 25% greater (P < 0.05) and that of chloride was 50% greater
(P < 0.01) in WKY than in SHR (Table 2). The mean sodium
excretion, which was 60% greater in SHR than WKY prior to
BFTZ, was no longer statistically significantly greater in SHR
after BFTZ. If the data are analyzed as the change in urinary
excretion elicited by BFTZ (BFTZ Es), the increase in excretion
averaged 80% greater in WKY in the case of chloride (P < 0.02)
and potassium (P < 0.05), but only 33% (P = 0.108) in the case
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Fig. 1. Urina#y calcium excretion before and after bendrofiumethiazide in
WKY (E') and SHR (iii) males. Urinary calcium, expressed as jrmol
calcium ÷ mole creatinine, is shown for the two hour periods be-
fore administration of bendrofiumethiazide, after bendrofiumethiazide
(BFTZ) and as the difference between the two periods (Delta). N = 10 in
each group.
to elicit greater changes in monovalent ion excretion in WKY than
in SHR. In sharp contrast, BFTZ reduced urinary excretion of the
calcium (Table 2 and Fig. 1) 53% in SHR (P = 0.005), but by a
statistically insignificant amount (18%) in WKY. As a conse-
quence, the urinary excretion of calcium, which had been 90%
greater in SHR prior to BFTZ, was statistically not different in the
two strains after BFTZ (Fig. 1).
Discussion
This study confirms the importance of the DCT as a renal locus
involved in the expression of hypercalciuria in SHR. However, the
urinary excretion rate for calcium is the same in SHR and WKY
in the first two hours following administration of a thiazide
diuretic (Table 2). This acute elimination of the difference
between strains would appear to be too rapid to result from
synthesis and restoration to abundance of some membrane pro-
tein limiting calcium reabsorption, such as the renal PMCAs.
Rapid correction of the hypercalciuria abnormality in SHR could
be produced, however, by alteration of the driving forces for
reabsorption of calcium across the DCT. Thiazide diuretics are
believed to produce alterations in the driving force for reabsorp-
tion of calcium in the DCT [15, 34]. Since the urinary excretion of
calcium after thiazide is the same in SHR and WKY, we propose
that the hypercalciuria in untreated SHR is a manifestation of
incomplete calcium uptake from the tubular lumen in DCT. The
present data do not enable speculation concerning whether
hypercalciuria in other forms of experimental and human hyper-
tension are similarly limited to the DCT.
Surprisingly, thiazide administration increased the excretion of
chloride (and of potassium and sodium at lesser levels of statisti-
cal significance) to a greater extent in WKY, the strain with the
lesser renal thiazide receptor content. Thus, the effects of thiazide
administration appear anomalous, since the strain of animals
(WKY) with the greater monovalent ion excretory response to the
diuretic had the lesser renal density of receptor for the diuretic.
One possible explanation of this apparent discrepancy is that
there is a difference between the quantity of the thiazide receptor
detected by the in vitro binding assay with 3H-metolazone, which
we used to quantitate receptor, and the amount of receptor
available or active in vivo. However, in the case of urinary
excretion of calcium, the effect of thiazide administration was
greater in the strain of animals (SHR) with the greater renal
density of diuretic receptor. This finding is compatible with the
presence of more functioning thiazide receptor in SHR. This
apparent contradiction in interpretation of the relationship be-
tween the renal content of thiazide receptor as detected by in vitro
binding assay and the in vivo effects of thiazide on urinary ion
excretion cannot be further addressed with the available data.
The lesser kaliuretic response to thiazide in SHR (Table 2) is
similar to that reported previously by Kau, Pritchard and Leszyn-
ska [35] in substrains of SHR obtained from three different
commercial suppliers. They also found a lesser natriuretic re-
sponse to chlorthalidone in SHR obtained from Charles River
and Harlan-Sprague-Dawley companies. It is pertinent to note
that SHRLJ were derived from animals supplied by Charles River.
The absolute rate of excretion of sodium after thiazide did not
differ between SHR and WKY (Table 2). Our data do not enable
distinction between two possible causes: (i) sodium reabsorption
in non-DCT tubule segments is the same in SHR and WKY or (ii)
lesser sodium reabsorption in one (or more) non-DCT segments
is compensated for by enhanced sodium reaborption in the DCT.
The indirect inferences provided by our data in this regard are
contradictory in that (a) elimination of the hypercalciuria by
thiazides would be compatible with enhanced delivery of sodium
to the DCT, an inference supported by direct micropuncture
studies [36, 37]; while on the other hand, (b) the lesser absolute
kaliuresis after thiazide (Table 2) could lead one to infer that
there is less sodium reabsorption in the collecting ducts in SHR,
an inference that would require enhanced reabsorption of sodium
prior to the DCT. These contradictory speculations cannot be
resolved by the present methodology.
The presence of hypercalciuria in genetic and experimental
hypertension in rodents and in some human populations with
"essential hypertension" [5, 10] could occur as a result of (a) an
increased rate of glomerular filtration of calcium, (b) a decreased
rate in the tubular reabsorption of calcium, or (c) some combi-
nation of these. Although our current study did not directly test
for increased glomerular filtration of calcium, the lesser concen-
tration of plasma total calcium in SHR than in WKY (Table 1)
can be used to argue against the possibility that SHR animals have
an increased quantity of filtered calcium.
Our data do not provide convincing information about the
relationship between hypertension and hypercalciuria. Hyperten-
sion and hypercalciuria could be genetically or pathogenetically
related to each other, or they could have been separately bred into
the strains, and, therefore, could be neither genetically nor
pathogenetically linked. We are currently engaged in genetic
breeding experiments in order to study this issue by genetic
segregation analysis.
To conclude, we postulate the following interpretation of our
findings: (a) the thiazide-sensitive segment in the hypertensive
SHR kidney usually reabsorbs calcium less completely than in the
WKY kidney, resulting in hypercalciuria; and (b) after acute
thiazide administration, calcium reabsorption in the thiazide-
sensitive portion of the nephron is maximally enhanced in both
SHR and WKY, resulting in virtual identity in urinary calcium
excretion. In summary, compared to WKY animals, the SHR
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strain of hypertensive rats are hypercalciuric, have kidneys with a
greater density of thiazide diuretic receptor and respond to
thiazide administration with a greater decrease in urinary excre-
tion of calcium. We postulate that incomplete uptake of calcium
from the tubule lumen across the apical membrane of DCT cells
in SHR kidney is the renal basis for hypercalciuria in SHR.
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